MCM
GILD icon

Masters Capital Management’s Gilead Sciences GILD Stock Holding History

Masters Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000,000
Closed -$111M – 84
2025
Q3 		$111M Buy
+1,000,000
New +$114M 4.02% 3
2025
Q1 		– Sell
-600,000
Closed -$55.4M – 79
2024
Q4 		$55.4M Sell
600,000
-400,000
-40% -$36M 2.05% 14
2024
Q3 		$83.8M Buy
1,000,000
+615,000
+160% +$46.9M 4.09% 4
2024
Q2 		$26.4M Buy
+385,000
New +$25.7M 1.49% 22
2022
Q4 		– Sell
-1,000,000
Closed -$61.7M – 54
2022
Q3 		$61.7M Hold
1,000,000
– – 4.37% 5
2022
Q2 		$61.8M Hold
1,000,000
– – 2.89% 8
2022
Q1 		$59.5M Buy
1,000,000
+400,000
+67% +$25.6M 2.39% 13
2021
Q4 		$43.6M Buy
600,000
+100,000
+20% +$6.89M 1.77% 17
2021
Q3 		$34.9M Buy
+500,000
New +$35.1M 1.44% 21
2021
Q2 		– Sell
-1,000,000
Closed -$64.6M – 73
2021
Q1 		$64.6M Buy
+1,000,000
New +$64.5M 2.16% 9
2018
Q4 		– Sell
-1,000,000
Closed -$77.2M – 66
2018
Q3 		$77.2M Buy
1,000,000
+514,500
+106% +$38.9M 1.91% 16
2018
Q2 		$34.4M Sell
485,500
-1,514,500
-76% -$107M 0.97% 30
2018
Q1 		$151M Hold
2,000,000
– – 3.27% 9
2017
Q4 		$143M Hold
2,000,000
– – 3.43% 8
2017
Q3 		$162M Buy
2,000,000
+1,000,000
+100% +$76.5M 3.78% 6
2017
Q2 		$70.8M Hold
1,000,000
– – 1.75% 15
2017
Q1 		$67.9M Sell
1,000,000
-2,948,000
-75% -$207M 1.68% 15
2016
Q4 		$283M Buy
3,948,000
+2,948,000
+295% +$219M 6.21% 5
2016
Q3 		$79.1M Buy
+1,000,000
New +$81.2M 1.59% 18
2016
Q2 		– Sell
-500,000
Closed -$45.9M – 65
2016
Q1 		$45.9M Sell
500,000
-500,000
-50% -$45.1M 0.96% 22
2015
Q4 		$101M Buy
1,000,000
+500,000
+100% +$52M 2.66% 11
2015
Q3 		$49.1M Buy
+500,000
New +$55.5M 1.66% 13

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Masters Capital Management's GILD Position: Q4 2021 in Review

Masters Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 600,000 shares — an estimated $41.3M sold.

Masters Capital Management first reported a position in GILD in Q4 2016 and held it in 10 quarters. The position peaked at $68.9M in Q2 2021. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Masters Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Masters Capital Management sold 600,000 Gilead Sciences shares in Q4 2021, an estimated $41.3M.
  • Masters Capital Management first reported a position in Gilead Sciences in Q4 2016 and held it in 10 quarters.
  • Masters Capital Management's Gilead Sciences position peaked at $68.9M in Q2 2021.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Masters Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.